Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Equity

Direct

Index Funds

NAV as on 03-02-2025

₹ 19.66

0.5%

1D

Inception Returns

17.1%

/yr

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is an equity fund. This fund was started on 26 October, 2020. The fund is managed by Bhavesh Jain. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has ₹158 Cr worth of assets under management (AUM) as on Nov 2024 and is less than category average.
  2. The fund has an expense ratio 0.5.

Returns

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has given a CAGR return of 17.13% since inception. Over the last 1 and 3 years the fund has given a CAGR return of 17.18% and 16.49% respectively.

Holdings

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Max Healthcare Institute Ltd Ordinary Shares, Dr Reddy's Laboratories Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd

Taxation

As it is a index funds mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has no lock in period.

Historical NAV & Returns

Absolute

zero opening, trading, fund transfer fee
3763 people have invested ₹ 28.1L in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth in the last three months

INDmoney Rank for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Powered by IND quant engine
IND ranking is not available for this fund.
img
3Y returns in the top 25% of the category
img
No bad points found for this fund.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Overview

Expense ratio0.5%
Benchmark
MSCI Ind Dom & Wld HealthC 45 NR INR
AUM₹158 Cr
Inception Date26 October, 2020
Min Lumpsum/SIP₹100/₹100
Exit Load0%
Lock InNo Lock-in
TurnOver
7.8%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Fund Distribution

as on (30-Nov-24)

  • Equity 99.7%

  • Debt & Cash 0.3%

Large cap
40.9%

Mid cap
25.3%

Small cap
4.4%

Sector Allocation

Dec'24

Nov'24

Oct'24

Health
100%
All changes are between Sep'24 and Nov'24
Nov'24
Oct'24
Sep'24
Fund Returns
-2.04%
-2.36%
0.62%
Nifty 50
-0.71%
-6.17%
2.11%
  • This fund’s returns stands at -2.04% whereas the fund’s underlying benchmark Nifty 50 returns stands at -0.71% as on Nov'24
  • This fund underperformed Nifty 50 by 1.32% in Nov'24
Parameters
Dec'24
Nov'24
Oct'24
AUM
₹ 153.7 Cr
₹ 153.7 Cr
₹ 156.7 Cr
  • AUM of the fund stands at 153.7 Cr as of Dec'24
  • AUM has remained same between Dec'24 and Nov'24
Top Stocks sold last month
Dr Reddy's Laboratories Ltd's allocation decreased from 5.92 % to 5.59 %
Dr Reddy's Laboratories Ltd's allocation decreased from 5.92 % to 5.59 %
Ipca Laboratories Ltd's allocation decreased from 5.26 % to 1.67 %
Ipca Laboratories Ltd's allocation decreased from 5.26 % to 1.67 %
Cash allocation has gone up from 0% to 0.3%
Cash allocation has gone up from 0% to 0.3%

Top Sector in December was Health

Dec'24
Health
100%
Nov'24
Health
100%
  • Gainers

  • Losers

Top Growth Drivers
1M Return
Biocon Ltd
Biocon Ltd
0.3%
Fund
Nov'24
Oct'24
Sep'24
No of Holdings
49
49
49
Top 5 Company Concentration
36.3%
36.3%
37.7%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (13.3%)
Sun Pharmaceuticals Industries Ltd (13.3%)
Sun Pharmaceuticals Industries Ltd (13.9%)
No of Sectors
1
1
1
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (100%)
Health (100%)
Health (100%)
Loading...
We are taking more time than usual
Bhavesh Jain
Bhavesh Jain
Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth, since 1 October 2021
Fund House
Edelweiss Asset Management Limited
Total AUM
₹1.05L Cr
as on 29-Nov-2024
Address
Edelweiss House, Off C.S.T. Road, Kalina
Phone
91-22-40979900
Website
investor.amc@edelcap.com

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 17.13% since inception which is more than its category average return of 9.93%
Fund Allocations

Fund Allocations

This fund has an allocation of 99.67% in Equity, 0% in Debt and 0.33% in Cash related instruments
AUM size ₹158 Cr

AUM size ₹158 Cr

This fund has AUM of ₹158 Cr which is less than its category average of ₹ 809 Cr
Expense Ratio 0.5%

Expense Ratio 0.5%

This fund has an expense ratio of 0.5% which is less than its category average expense ratio of 0.54%

Frequently Asked Questions for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

The current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is ₹19.66 as on 03-Feb-2025.
Existing (Absolute + CAGR) as on 03-Feb-2025.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
-3.53%
-3.53%
6 Month Returns
0.75%
0.75%
1 Year Returns
17.18%
17.18%
3 Years Returns
58.07%
16.49%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.5% as on January 2025
₹158 Cr as on January 2025
Sun Pharmaceuticals Industries Ltd(12.86%), Max Healthcare Institute Ltd Ordinary Shares(6.23%), Dr Reddy's Laboratories Ltd(5.76%), Cipla Ltd(5.7%), Apollo Hospitals Enterprise Ltd(5.22%) as on January 2025
The alpha ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
-
-
-
As on January 2025
The alpha for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated against MSCI Ind Dom & Wld HealthC 45 NR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
-
-
-
As on January 2025
The Beta for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated with MSCI Ind Dom & Wld HealthC 45 NR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
0.81
0.81
-
As on January 2025
The sharpe ratio for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated with MSCI Ind Dom & Wld HealthC 45 NR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
11.86
13.12
-
As on January 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.5 as on January 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Bhavesh Jain is the fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
The Exit load of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is 0%